This study will look at the impact of ascorbic acid (Vitamin C) on the progression of disease
in people with CMT1A as compared to volunteers receiving a placebo. This study will assess
whether is it futile to proceed with a larger, longer-term, placebo-controlled study.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Wayne State University
Collaborators:
Charcot-Marie-Tooth Association Muscular Dystrophy Association